Interleukin-6 (-174G>C) promoter polymorphism in patients infected by hepatitis B virus

Journal Title: Journal of Experimental and Integrative Medicine - Year 2012, Vol 2, Issue 2

Abstract

Objective: Hepatitis B virus (HBV) infection is one of the most important health problems in the world. Interleukin-6 (IL-6) has been shown to be a major inflammatory cytokine, inducing cell proliferation and expression of acute response genes, such as fibrinogen and C-reactive protein in hepatocytes. IL-6 levels are elevated in patients acutely infected with HBV and have been associated with progression of infection to chronic hepatitis. Methods: In the present study, the role of IL-6 (-174G/C) polymorphism was investigated on individuals which are diagnosed as hepatitis B virus carrier (n=19), chronic hepatitis (n=10) and cirrhosis (n=13), and non-infected individuals with HBV (n=8). In order to determine IL-6 polymorphism, the polymerase chain reaction-restriction fragment length polymorphism (PCR-RFLP) method was applied using genomic DNA extracted from paraffin embedded liver needle biopsy specimens. Results: The genotype frequencies in 50 samples were observed as follows: 76% homozygote typical (GG), 22% heterozygote (GC) and 2% homozygote atypical (CC). In this study, limited statistical association was observed between IL-6 polymorphism (GG, GC and CC genotype) and chronic hepatitis/cirrhosis compared to hepatitis B virus carriers and non-infected individuals with HBV (p=0.045). Conclusion: As observed in only one patient with chronic hepatitis, IL-6 (-174C/C) genotype is very rare in this study group. Because of lower frequency of -174C/C phenotype, studies in larger series can give statistically more precise conclusions.

Authors and Affiliations

Serap Yalcin, Seref Demirbas, Onder Onguru

Keywords

Related Articles

Towards TRAIL to silencing of SMURF and NEDD4: FLIP is flopped

Objective: Prostate cancer is a multifactorial anomaly that arises and exacerbates because of miscellaneous key mediators instrumental in disease aggressiveness. Heterogeneity of the disease offers stumbling blocks in st...

Interleukin-6 (-174G>C) promoter polymorphism in patients infected by hepatitis B virus

Objective: Hepatitis B virus (HBV) infection is one of the most important health problems in the world. Interleukin-6 (IL-6) has been shown to be a major inflammatory cytokine, inducing cell proliferation and expression...

Immunomodulatory activities of five clinically used Chinese herbal polysaccharides

Polysaccharide is a natural macromolecular compound with complex, important and multifaceted biological activities. Some of polysaccharides have been marketed in China as drugs or healthy products. More studies confirm...

Hepatoprotective effect of Piper guineense aqueous extract against ethanol-induced toxicity in male rats

[b]Objective: [/b]Herbal medicinal products play an important role in the management of liver diseases for the lack of satisfactory liver protective drugs in allopathic medical practices. Searching for hepatoprotective d...

Epigenetic mechanisms in human physiology and diseases

Although the sequence of human genome is known, our understanding of the complicated network that takes place inside cells is far from complete. Many questions still remain unanswered with the regard to how the complex g...

Download PDF file
  • EP ID EP86728
  • DOI 10.5455/jeim.230112.or.022
  • Views 120
  • Downloads 0

How To Cite

Serap Yalcin, Seref Demirbas, Onder Onguru (2012). Interleukin-6 (-174G>C) promoter polymorphism in patients infected by hepatitis B virus. Journal of Experimental and Integrative Medicine, 2(2), 173-177. https://europub.co.uk/articles/-A-86728